1.The Choice of First-line Therapy and Combination Therapy in Disease Management of Hypertension.
Journal of the Korean Academy of Family Medicine 2002;23(5):565-572
No abstract available.
Disease Management*
;
Hypertension*
2.Obesity and Cardiovascular Disease.
Korean Circulation Journal 1997;27(1):130-134
No abstract available.
Cardiovascular Diseases*
;
Obesity*
3.Principles in the Treatment of Hypertension in the Elderly and New Classes of Antihypertensive Agents.
Journal of the Korean Geriatrics Society 2000;4(4):231-243
No abstract available.
Aged*
;
Antihypertensive Agents*
;
Humans
;
Hypertension*
4.A clinical review of the 188 cases of peptic ulcer perforations.
Chang Beum CHO ; Byeong Eyong SEOL ; Mun Gyu PARK
Journal of the Korean Surgical Society 1992;43(3):344-353
No abstract available.
Peptic Ulcer Perforation*
;
Peptic Ulcer*
5.Physical Gowth According to Sexual Maturation of Korean Adolescents.
Hwan Gyu PARK ; Chang Ho HONG ; Duk Hi KIM
Journal of the Korean Pediatric Society 1994;37(9):1187-1195
Adolescence is the period in which physical, mental and social maturation occurs and it is an important transit stage, changing from childhood to adulthood. This is a period in which important changes occur physically such as rapid growth in height and weight gain but significant differences in growth may occur for the same age. Therfore, the degree of sexual maturation may be an important indicator in evaluating growth in adolescence. Six thousand five hundred and eighty six male and female students from grade 4 to senior high from Seoul, district town and countryside were evaluated for sexual maturity using Tanner staging, weight, height and body mass index and compared for growth. There was a rapid growth in height of 6.7cm in boys between the ages of 11 and 14 years and 6.3 cm in height for girls between the ages of 10 and 12 years, showing earlier growth in height for girls. Growth in height according to sexual maturation showed the greatest growth during stages 2~3 for boys and girls. Boys grew an average of 18.94 cm and girls an average of 18.03 cm in height during the whole sexual maturation period. There was an increase of 5.5 kg in weight for boys during the same age as for growth in height, that is between 11 and 14 years of age. In girls, an average weight gain of 5.1 kg occurred between 11 and 13 years of age, slightly later than that of growth in height. Rapid gain in weight occurred during Tanner stages 2~3 for girls. Total gain of 20.70 kg for boys occurred during the whole sexual maturation period while girls gained total 19.73 kg. Body mass index increased gradually during the whole adolescent period. It was greater in boys during the ages of 9 and 12 years and greater in girls the age of 13 years and again in boys after 17 years of age. During the whole maturation period, boys gained 3.24 and girls, 4.05 of body mass index showing more gain in girls. Height, weight and body mass index showed normal variations during the sexual maturation index showed normal variations during the sexual maturation period and the results may bring an increased understanding that adolescent physical growth was closely related to sexual maturation.
Adolescent*
;
Body Mass Index
;
Female
;
Humans
;
Male
;
Seoul
;
Sexual Maturation*
;
Weight Gain
6.Characteristic angiographic findings of thromboangiitis obliterans
Choong Ki PARK ; Joon Young NHO ; Woo Cheol HWANG ; Sang Gyu PARK ; Chang Sig CHOI
Journal of the Korean Society for Vascular Surgery 1992;8(1):20-27
No abstract available.
Thromboangiitis Obliterans
7.The Comparison Study of teh Effect of Ambroxol on Prevention of Infantile Respiratory Distress Syndrome in Preterm Delivery.
Kyung Hwan HAN ; Jung Don PARK ; Chi Dong HAN ; Chang Gyu HUH ; Soon Gu HWONG
Korean Journal of Perinatology 1997;8(1):21-26
This study was conducted to evaluate the effect of ambroxol on preventing the infantile respiratory distress syndrome (IRDS) in preterm birth at the Dept. of Obstetrics and Gynecology of Taegu Catholic Medical Center during the period from Jan. 1996 to Dec. 1996. Total of 68 cases were evaluated including 16 ambroxol group and 52 control group. The result were as follows : 1. In the comparison of preventing IRDS, there was 0 case of IRDS in ambroxol group and 7 cases of IRDS in control group (13.46 %). There was a significant difference between two groups (p<0.05). 2. The side effects of ambroxol after administration were nausea in 5 cases, headache in 3 cases, and chest discomfort in 4 cases, but these were not serious and self controlled. 3. There was no significant difference in neonatal morbidity between two groups (p > 0.05).
Ambroxol*
;
Daegu
;
Gynecology
;
Headache
;
Nausea
;
Obstetrics
;
Premature Birth
;
Respiratory Distress Syndrome, Newborn*
;
Thorax
8.The Significance of the J-Curve in Hypertension and Coronary Artery Diseases.
Korean Circulation Journal 2011;41(7):349-353
The J-curve effect describes an inverse relation between low blood pressure (BP) and cardiovascular complications. This effect is more pronounced in patients with preexisting coronary artery disease (CAD), hypertension or left ventricular hypertrophy (LVH). The recent large clinical outcomes trials have observed a J-curve effect between a diastolic BP of 70-80 mmHg as well as a systolic BP <130 mmHg. The J-curve phenomenon does not appear in stroke or renal disease. This is because the coronary arteries are perfused during diastole, but the cerebral and renal perfusion mainly occurs in systole. Therefore, caution should be taken to maintain the diastolic blood pressure (DBP) at minimum of 70 mmHg and possibly to maintain the DBP between 80-85 mmHg in patients with severe LVH, CAD or vascular diseases. BP control in high-risk elderly patients should be carefully done as undergoing aggressive therapy to lower the systolic blood pressure below 140 mmHg can cause cardiovascular complications due to the severely reduced DBP and increased pulse pressure.
Aged
;
Blood Pressure
;
Coronary Artery Disease
;
Coronary Vessels
;
Diastole
;
Humans
;
Hypertension
;
Hypertrophy, Left Ventricular
;
Hypotension
;
Perfusion
;
Stroke
;
Systole
;
Vascular Diseases
9.Is amlodipine more cardioprotective than other antihypertensive drug classes?.
The Korean Journal of Internal Medicine 2014;29(3):301-304
No abstract available.
Amlodipine/*therapeutic use
;
Antihypertensive Agents/*therapeutic use
;
Blood Pressure/*drug effects
;
Calcium Channel Blockers/*therapeutic use
;
Heart Failure/*prevention & control
;
Humans
;
Hypertension/*drug therapy
;
Myocardial Infarction/*prevention & control
;
Stroke/*prevention & control
10.Pseudotype HIV-1 Particles Carrying CD4.
Seung Won PARK ; Tai Gyu KIM ; Ji Chang YOU ; Manfred SCHUBERT ; Soon Young PAIK
Journal of the Korean Society of Virology 2000;30(1):83-99
A defective HIV-1 helper virus DNA, pHyPC, was assembled by deleting the RNA packaging signal, env, nef and the 3'LTR sequences. HIV-1 like virus particles that carry the HIV-1 receptor, CD4 were generated by coexpression of pHyPC and plasmid DNAs encoding different chimeric CD4 proteins. The CD4 particles, sharing the CD4 ectodomain, precisely fused to different membrane anchors. CD4(+) particles specifically bound to HIV-1 Env expressing cells, but any signs of infection into these cells were not detected. Binding was only partially blocked by either polyclonal anti-CD4 antibodies or by high concentrations of soluble CD4. Suprisingly, CD4(+) particles also adsorbed to HeLa, CHO, NIH3T3 and COS-7 cells in the absence of HIV-1 Env expression. Adsorption was comparable in strength and speed to the highly specific CD4-Env interaction. CD4(-) particles exhibited only background levels of binding. Cell binding was CD4- dependent, but it was independent of the cell type from which the CD4(+) particles originated. Interestingly, CD4-dependent/Env-independent binding was only found when CD4 was present on virus particles. This suggests that the micro-environment of CD4 on virus particles uniquely expose this new cell binding activity. Its high affinity could explain in part why infection of Env(+) cells by CD4(+) particles was not detected. Further experiments will be required to evlauate whether this strong membrane interaction could represent one step in the multiple-step viral entry process.
Adsorption
;
Animals
;
Antibodies
;
COS Cells
;
DNA
;
Helper Viruses
;
HIV-1*
;
Membranes
;
Plasmids
;
Product Packaging
;
RNA
;
Virion